CWM
Cranbrook Wealth Management’s Thermo Fisher Scientific TMO Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $423K | Hold |
1,044
| – | – | 0.09% | 86 |
|
|
2025
Q1 | $519K | Sell |
1,044
-29
| -3% | -$14.4K | 0.12% | 76 |
|
|
2024
Q4 | $558K | Hold |
1,073
| – | – | 0.13% | 74 |
|
|
2024
Q3 | $664K | Hold |
1,073
| – | – | 0.15% | 69 |
|
|
2024
Q2 | $593K | Buy |
1,073
+1,007
| +1,526% | +$557K | 0.15% | 67 |
|
|
2024
Q1 | $38.4K | Hold |
66
| – | – | 0.01% | 174 |
|
|
2023
Q4 | $35K | Hold |
66
| – | – | 0.01% | 174 |
|
|
2023
Q3 | $33.4K | Hold |
66
| – | – | 0.01% | 170 |
|
|
2023
Q2 | $34.4K | Hold |
66
| – | – | 0.01% | 174 |
|
|
2023
Q1 | $38K | Hold |
66
| – | – | 0.01% | 167 |
|
|
2022
Q4 | $36.3K | Hold |
66
| – | – | 0.01% | 173 |
|
|
2022
Q3 | $33K | Hold |
66
| – | – | 0.01% | 192 |
|
|
2022
Q2 | $36K | Hold |
66
| – | – | 0.01% | 188 |
|
|
2022
Q1 | $39K | Hold |
66
| – | – | 0.01% | 202 |
|
|
2021
Q4 | $44K | Hold |
66
| – | – | 0.01% | 193 |
|
|
2021
Q3 | $38K | Buy |
66
+20
| +43% | +$11.5K | 0.01% | 212 |
|
|
2021
Q2 | $23K | Sell |
46
-27
| -37% | -$13.5K | 0.01% | 233 |
|
|
2021
Q1 | $33K | Buy |
73
+27
| +59% | +$12.2K | 0.01% | 215 |
|
|
2020
Q4 | $21K | Hold |
46
| – | – | 0.01% | 204 |
|
|
2020
Q3 | $20K | Hold |
46
| – | – | 0.01% | 182 |
|
|
2020
Q2 | $17K | Hold |
46
| – | – | 0.01% | 186 |
|
|
2020
Q1 | $13K | Hold |
46
| – | – | ﹤0.01% | 188 |
|
|
2019
Q4 | $15K | Hold |
46
| – | – | ﹤0.01% | 191 |
|
|
2019
Q3 | $13K | Hold |
46
| – | – | ﹤0.01% | 191 |
|
|
2019
Q2 | $14K | Hold |
46
| – | – | ﹤0.01% | 185 |
|
|
2019
Q1 | $13K | Hold |
46
| – | – | ﹤0.01% | 187 |
|
|
2018
Q4 | $10K | Hold |
46
| – | – | ﹤0.01% | 186 |
|
|
2018
Q3 | $11K | Hold |
46
| – | – | ﹤0.01% | 181 |
|
|
2018
Q2 | $10K | Buy |
+46
| New | +$10K | ﹤0.01% | 179 |
|